Estriol: A potent regulator of TNF and IL-6 expression in a murine model of endotoxemia

Inflammation

Volumn 20, Issue 6, 1996, Pages 581-597

  Zuckerman, Steven H ^a   Ahmari, Susanne E ^b   Bryan Poole, Nancy ^a   Evans, Glenn F ^a   Short, Lorri ^c   Glasebrook, Andrew L ^c  

^a Divisions of Endocrine Research   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ENDOTOXIN; ESTRIOL; ESTROGEN; INTERLEUKIN 1; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; MONOKINE; SEX HORMONE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; BLOOD LEVEL; CELL CULTURE; CONTROLLED STUDY; ENDOTOXEMIA; EPIDEMIOLOGY; FEMALE; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PATHOGENESIS; PERITONEUM MACROPHAGE; PREMENOPAUSE; PROVOCATION TEST;

ANIMALS; AUTOIMMUNE DISEASES; CELLS, CULTURED; ENDOTOXEMIA; ESTRADIOL; ESTRIOL; ESTROGEN ANTAGONISTS; ESTROGENS; ESTRONE; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INCIDENCE; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; MICE, INBRED STRAINS; MICE, MUTANT STRAINS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; TAMOXIFEN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030472127     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf01488797     Document Type: Article

References (40)

1. WALSH, R. W., I. SCHIFF, B. ROSNER, L. GREENBERG, V. RAVNIKAR, and F. M. SACKS. 1991. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. New England J. Med. 325:1196.
2. STAMPFER, M. J., G. A. COLDITZ, W. C. WILLETT, J. E. MANSON, B. ROSNER, F. E. SPEIZER, and C. H. HENNEKES. 1991. Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the nurse's health study. New England J. Med. 325:756.
3. SCHAEFER, E. J., D. M. FOSTER, L. A. ZECH, F. T. LINDGREN, H. B. BREWER, and R. I. LEVY. 1983. The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females. J. Clin. Endocrinol. Metab. 57:262.
4. COLVIN, P. L., B. J. AUERBACH, L. D. CASE, W. R. HAZZARD, and D. APPLEBARUM-BOWDEN. 1991. A dose-response relationship between sex hormone-induced change in hepatic triglyceride lipase and high density lipoprotein cholesterol in postmenopausal women. Metabolism 40:1052.
5. ROSS, R. 1995. Cell biology of atherosclerosis. Annu. Rev. Physiol. 57:791.
6. STEMME, S. and G. K. HANSSON. 1994. Immune mechanisms in atherogenesis. Ann. Med. 26:141.
7. GALIS, Z. S., G. K. SUKHOVA, R. KRANZHOFER, S. CLARK, and P. LIBBY. 1994. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc. Natl. Acad. Sci. U.S.A. 92:402.
8. GULSHAN, S., A. MCCRUDEN, and W. STIMSON. 1990. Oestrogen receptors in macrophages. Scand. J. Immunol. 31:691.
9. MAZIERE, C., M. AUCLAIR, M-F. RONVEAUX, S. SALMON, S. RANTUS, and J-C. MAZIERE. 1991. Estrogens inhibit copper and cell-mediated modification of low density lipoprotein. Atherosclerosis 89:175.
10. HUBER, L. A., E. SCHEFFLER, T. POLL, R. ZIEGLER, and H. A. DRESEL. 1990. 17 beta-estradiol inhibits LDL oxidation and cholesteryl ester formation in cultured macrophages. Free Rad. Res. Comm. 8:167.
11. STOCK, J. L., J. A. CODERRE, B. MCDONALD, and L. J. ROSENWASSER. 1989. Effects of estrogen in vivo and in vitro on spontaneous interleukin-1 release by monocytes from postmenopausal women. J. Clin. Endocrinol. Metab. 68:364.
12. PACIFICI, R., L. RIFAS, R. MCCRACKEN, I. VERED, C. MCMURTRY, L. V. AVIOLI, and W. A. PECK. 1989. Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release. Proc. Natl. Acad. Sci. U.S.A. 86:2398.
13. HU, S. K., Y. L. MITCHO, and N. C. RATH. 1988. Effect of estradiol on interleukin 1 synthesis by macrophages. Int. J. Immunopharmacol. 10:247.
14. MORI, H., M. SAWAIRI, N. ITOH, T. HANABAYASHI, and T. TAMAYA. 1992. Effects of sex steroids on cell differentiation and interleukin-1 beta production in the human promyelocytic leukemia cell line HL-60. J. Reprod. Med. 37:871.
15. LOY, R. A., J. A. LOUKIDES, and M. L. POLAN. 1992. Ovarian steroids modulate human monocyte tumor necrosis factor alpha messenger ribonucleic acid levels in cultured human peripheral monocytes. Fertil. Steril. 58:733.
16. CHAO, T-C., P. J. ALTEN, J. A. GREAGER, and R. J. WALTE. 1995. Steroid sex hormones regulate the release of tumor necrosis factor by macrophages. Cell Immunol. 160:43.
17. 2/IL-6 by freshly explanted human endometrial stromul cells. Modulation by estradiol-17β. J. Immunol. 142:3134.
18. GIRASOLE, G., R. L. JILKA, G. PASSERI, G. BOSWELL, G. BODER, D. C. WILLIAMS, and S. C. MANOLAGAS. 1992. 17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J. Clin. Invest. 89:883.
19. FRAZIER-JESSEN, M. R., and E. J. KOVACS. 1995. Estrogen modulation of JE/monocyte chemoattractant protein-1 mRNA expression in murine macrophages. J. Immunol. 154:1838.
20. SHANKER, G., M. SORCI-THOMAS, and M. R. ADAMS. 1995. Estrogen modulates the inducible expression of platelet-derived growth factor mRNA by monocyte/macrophages. Life Sci. 56:499.
21. HOLMDAHL, R. 1989. Estrogen exaggerates Lupus but suppresses T-cell dependent autoimmune disease. J. Autoimmun. 2:651.
22. VANDENBROUCKE, J. P., H. A. VALKENBURG, J. W. BOERSMA, A. CATS, J. J. M. FESTEN, O. HUBER-BRUNING, and J. J. RASKE. 1982. Oral contraceptives and rheumatoid arthritis: further evidence for a preventive effect. Lancet ii: 839.
23. HOLMDAHL, R., L. JANSSON, B. MEYERSON, and L. KLARESKOG. 1987. Oestrogen induced suppression of collagen induced arthritis: I. Long term oestradiol treatment of DBA/1 mice reduces the severity and incidence of arthritis and decrease the anti-type II collagen immune response. Clin. Exp. Immunol. 70:372.
24. VAN VOLLENHOVEN, R. F., and J. L. MCGUIRE. 1994. Estrogen, progesterone, and testosterone: Can they be used to treat autoimmune diseases? Cleveland Clin. J. Med. 61:276.
25. ROUBINIAN, J. R., N. TALAL, J. S. GREENSPAN, J. R. GOODMAN, and P. K. SIITERI. 1978. Effect of castration and sex hormone treatment on survival, anti nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice. J. Exp. Med. 147:1568.
26. CARLSTEN, H., N. NILSSON, R. JONSSON, K. BACKMAN, R. HOLMDAHL, and A. TARKOWSKI. 1992. Estrogen accelerates immune complex glomerulonephritis but ameliorates T cell mediated vasculitis and sialadenitis in autoimmune MRL lpr/lpr mice. Cell Immunol. 144:190.
27. CLARK, J. H., W. T. SCHRADER, and B. W. O'MALLEY. 1992. Mechanisms of action of steroid hormones. In: Williams Textbook of Endocrinology. (eds. J. D. Wilson and D. W. Foster), W. B. Saunders Co. 8th edition, p. 72.
28. SASSON. S. 1991. Equilibrium binding analysis of estrogen agonists and antagonists: Relation to the activation of the estrogen receptor. Path. Biol. 39:59.
29. SHEEHAN, K. C. F., N. H. RUDDLE, and R. D. SCHREIBER. 1989. Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors. J. Immunol. 142:3884.
30. ZUCKERMAN, S. H., N. BRYAN-POOLE, G. F. EVANS, L. SHORT, and A. L. GLASEBROOK. 1995. In vivo modulation of murine serum TNF and IL-6 levels during endotoxemia by estrogen agonists and antagonists. Immunol. 86:18.
31. STUEHR, D. J., and C. F. NATHAN. 1989. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med. 169:1543.
32. FRIEDMAN, D., F. NETTI, and A. D. SCHREIBER. 1985. Effects of estradiol and steroids on the clearance of Immunoglobulin G coated erythrocytes. J. Clin. Invest. 75:162.
33. FUJIMOTO, J., M. HORI, T. ITOH, S. ICHIGO, M. NISHIGAKI, and T. TAMAYA. 1995. Danazol decreases transcription of estrogen receptor gene in human monocytes. Gen. Pharm. 26:507.
34. +T lymphocytes in normal and rheumatoid synovium. Arthrit. Rheum. 36:1087.
35. RAY, A., K. E. PREFONTAINE, and P. RAY. 1994. Down modulation of interleukin-6 gene expression by 17β-estradiol in the absence of high affinity DNA binding by the estrogen receptor. J. Biol. Chem. 269:12940.
36. ZUCKERMAN, S. H., and N. BRYAN-POOLE. 1995. Estrogen induced alterations in lipoprotein metabolism in autoimmune MRL/lpr mice. Arterioscler. Thromb. Vasc. Biol. 15:1556.
37. TEREBUH, P. D., I. G. OTTERNESS, R. M. STRIETER, P. M. LINCOLN, J. M. DANFORTH, S. L. KUNKEL, and S. W. CHENSUE. 1992. Biologic and immunohistochemical analysis of interleukin-6 expression in vivo. Amer. J. Pathol. 140:649.
38. EVANS, G. F., and S. H. ZUCKERMAN. 1991. Glucocorticoid-dependent and independent mechanisms involved in lipopolysaccharide tolerance. Eur. J. Immunol. 21:1973.
39. AKIRA, S., T. TAGA, and T. KISHIMOTO. 1993. Interleukin-6 in biology and medicine. Adv. Immunol. 54:1.
40. FATTORI, E., M. CAPPELLETTI, P. COSTA, C. SELLITTO, L. CANTONI, M. CARELLI, R. FAFFIONI, G. FANTUZZI, P. GHEZZI, and V. POLI. 1994. Defective inflammatory response in Interleukin 6-deficient mice. J. Exp. Med. 180:1243.